However, there have been a few subsequent studies with conflicting evidence, such that RECQL1 appears to be a moderate breast cancer risk gene that needs further study (Bogdanova et al., 2017; Li et al., 2018a; Nguyen-Dumont et al., 2018). The gene discussed is RECQL; the disease is breast carcinoma.